Cargando…
Canakinumab in a subgroup of patients with COVID-19
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272172/ https://www.ncbi.nlm.nih.gov/pubmed/32835251 http://dx.doi.org/10.1016/S2665-9913(20)30167-3 |
| _version_ | 1783542213667454976 |
|---|---|
| author | Ucciferri, Claudio Auricchio, Antonio Di Nicola, Marta Potere, Nicola Abbate, Antonio Cipollone, Francesco Vecchiet, Jacopo Falasca, Katia |
| author_facet | Ucciferri, Claudio Auricchio, Antonio Di Nicola, Marta Potere, Nicola Abbate, Antonio Cipollone, Francesco Vecchiet, Jacopo Falasca, Katia |
| author_sort | Ucciferri, Claudio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7272172 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72721722020-06-05 Canakinumab in a subgroup of patients with COVID-19 Ucciferri, Claudio Auricchio, Antonio Di Nicola, Marta Potere, Nicola Abbate, Antonio Cipollone, Francesco Vecchiet, Jacopo Falasca, Katia Lancet Rheumatol Article Elsevier Ltd. 2020-08 2020-06-04 /pmc/articles/PMC7272172/ /pubmed/32835251 http://dx.doi.org/10.1016/S2665-9913(20)30167-3 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Ucciferri, Claudio Auricchio, Antonio Di Nicola, Marta Potere, Nicola Abbate, Antonio Cipollone, Francesco Vecchiet, Jacopo Falasca, Katia Canakinumab in a subgroup of patients with COVID-19 |
| title | Canakinumab in a subgroup of patients with COVID-19 |
| title_full | Canakinumab in a subgroup of patients with COVID-19 |
| title_fullStr | Canakinumab in a subgroup of patients with COVID-19 |
| title_full_unstemmed | Canakinumab in a subgroup of patients with COVID-19 |
| title_short | Canakinumab in a subgroup of patients with COVID-19 |
| title_sort | canakinumab in a subgroup of patients with covid-19 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272172/ https://www.ncbi.nlm.nih.gov/pubmed/32835251 http://dx.doi.org/10.1016/S2665-9913(20)30167-3 |
| work_keys_str_mv | AT ucciferriclaudio canakinumabinasubgroupofpatientswithcovid19 AT auricchioantonio canakinumabinasubgroupofpatientswithcovid19 AT dinicolamarta canakinumabinasubgroupofpatientswithcovid19 AT poterenicola canakinumabinasubgroupofpatientswithcovid19 AT abbateantonio canakinumabinasubgroupofpatientswithcovid19 AT cipollonefrancesco canakinumabinasubgroupofpatientswithcovid19 AT vecchietjacopo canakinumabinasubgroupofpatientswithcovid19 AT falascakatia canakinumabinasubgroupofpatientswithcovid19 |